Harmony Biosciences
Harmony Biosciences is a privately-owned biopharmaceutical company headquartered in Plymouth Meeting, USA.
The company was established in October 2017 by biopharmaceutical incubator and investment firm, Paragon Biosciences, with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with patients who live with narcolepsy.
Latest Harmony Biosciences News & Features
2 May 2024
30 April 2024
4 September 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze